➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Merck
Moodys
Mallinckrodt
AstraZeneca

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

Clinigen Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CLINIGEN, and when can generic versions of CLINIGEN drugs launch?

CLINIGEN has three approved drugs.

There is one US patent protecting CLINIGEN drugs.

There are nineteen patent family members on CLINIGEN drugs in sixteen countries.

Summary for Clinigen
International Patents:19
US Patents:1
Tradenames:3
Ingredients:3
NDAs:3

Drugs and US Patents for Clinigen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 AP RX Yes Yes   Start Trial   Start Trial
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 RX Yes Yes   Start Trial   Start Trial
Clinigen TOTECT dexrazoxane hydrochloride INJECTABLE;INJECTION 022025-001 Sep 6, 2007 RX Yes Yes 6,727,253   Start Trial   Start Trial
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Clinigen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 5,591,731   Start Trial
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 5,242,471   Start Trial
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 5,994,409   Start Trial
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 4,665,062   Start Trial
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 5,591,731   Start Trial
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 4,215,113   Start Trial
Clinigen TOTECT dexrazoxane hydrochloride INJECTABLE;INJECTION 022025-001 Sep 6, 2007 6,727,253   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for CLINIGEN drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe For Injection 500 mg/vial ➤ Subscribe 2004-04-16
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
AstraZeneca
Moodys
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.